EcoDrugPlus

Nicastrin

Ensembl ID : ENSSFOG00015012689
Gene Symbol: NCSTN
3 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSSFOG00015006148
Gene Symbol: NAMPT
3 Cross references
223 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSSFOG00015011238
Gene Symbol: NAMPT
3 Cross references
223 Possible Orthologues:

Nischarin

Ensembl ID : ENSSFOG00015002444
Gene Symbol: NISCH
1 Cross references
208 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSSFOG00015012124
Gene Symbol: NOS2
3 Cross references
165 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSSFOG00015001412
Gene Symbol: NOTCH1
3 Cross references
265 Possible Orthologues:

Notch Receptor 1b

Ensembl ID : ENSSFOG00015012709
Gene Symbol: NOTCH1B
1 Cross references
265 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSSFOG00015023784
Gene Symbol: NOTCH3
1 Cross references
199 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSSFOG00015003178
Gene Symbol: NFKB1
3 Cross references
198 Possible Orthologues:

Nuclear Factor, Erythroid 2 Like 2

Ensembl ID : ENSSFOG00015001827
Gene Symbol: NFE2L2
3 Cross references
216 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 4

Ensembl ID : ENSSFOG00015004131
Gene Symbol: NR1H4
3 Cross references
387 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 1

Ensembl ID : ENSSFOG00015000680
Gene Symbol: NR3C1
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).